Cite
No evidence for amyloid pathology as a key mediator of neurodegeneration post-stroke - a seven-year follow-up study
MLA
Guri Hagberg, et al. “No Evidence for Amyloid Pathology as a Key Mediator of Neurodegeneration Post-Stroke - a Seven-Year Follow-up Study.” BMC Neurology, vol. 20, no. 1, May 2020, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s12883-020-01753-w.
APA
Guri Hagberg, Hege Ihle-Hansen, Brynjar Fure, Bente Thommessen, Håkon Ihle-Hansen, Anne Rita Øksengård, Mona K. Beyer, Torgeir B. Wyller, Ebba Gløersen Müller, Sarah T. Pendlebury, & Per Selnes. (2020). No evidence for amyloid pathology as a key mediator of neurodegeneration post-stroke - a seven-year follow-up study. BMC Neurology, 20(1), 1–11. https://doi.org/10.1186/s12883-020-01753-w
Chicago
Guri Hagberg, Hege Ihle-Hansen, Brynjar Fure, Bente Thommessen, Håkon Ihle-Hansen, Anne Rita Øksengård, Mona K. Beyer, et al. 2020. “No Evidence for Amyloid Pathology as a Key Mediator of Neurodegeneration Post-Stroke - a Seven-Year Follow-up Study.” BMC Neurology 20 (1): 1–11. doi:10.1186/s12883-020-01753-w.